SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.175-18.6%Jan 15 10:50 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Laurens who wrote (651)2/10/1999 2:43:00 PM
From: MARK TANAKA  Read Replies (2) of 900
 
to all,

great quarter.

-sequential quarterly sales up, 17.6mil q3 98, to 21.9mil, q4 98.
24% increase qtr to qtr.

-cost of good sold decreasing, which increases gross margins.

selling more and making more off what they sell... positive mo

-The Company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration in December 1998 for EVACET(TM).

regards,

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News